Equities

Bioxyne Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Bioxyne Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.054
  • Today's Change-0.001 / -1.82%
  • Shares traded1.24m
  • 1 Year change+134.78%
  • Beta1.4192
Data delayed at least 20 minutes, as of Mar 13 2026 05:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Bioxyne Ltd (BXN:ASX) closed at 0.054, -12.90% below its 52-week high of 0.062, set on Feb 27, 2026.
52-week range
Today
0.02May 06 20250.062Feb 27 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.055
High0.0555
Low0.053
Bid0.053
Offer0.057
Previous close0.055
Average volume3.08m
Shares outstanding2.24bn
Free float960.58m
P/E (TTM)13.85
Market cap120.96m AUD
EPS (TTM)0.0039
AUD
Data delayed at least 20 minutes, as of Mar 13 2026 05:10 BST.
More ▼

Events & Activity

  • BXN:ASX price moved over -1.72% to 0.057
  • BXN:ASX price rises above 15-day moving average to 0.0555 at 04:04 BST
  • BXN:ASX price falls below 15-day moving average to 0.054 at 04:06 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.